Lithium Carbonate: Clinical Trials

23 trials of Lithium Carbonate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 5 terminated, 1 recruiting, 1 unknown. 23 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 323Completed 16, Terminated 5, Recruiting 1, Unknown 1
Phase 24Completed 2, Recruiting 1, Terminated 1

Follow Lithium Carbonate: new trials by email Literature Review of Lithium Carbonate trials Research Report on Lithium Carbonate

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment
Lithium Carbonate Capsule - Cornelia De Lange Syndrome
Phase 2 / Phase 3RecruitingUniversity of Milan342024-05-012025-01-28
Effect of Lithium in Patients With Autism Spectrum Disorder and Phelan-McDermid Syndrome (SHANK3 Haploinsufficiency)
Lithium Carbonate, Placebo - Autism Spectrum Disorder
Phase 3CompletedAssistance Publique - Hôpitaux de Paris222022-02-212025-10-02
A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction
Lithium Carbonate, Placebo - Carotid Artery Diseases, Carotid Artery Stenosis
Phase 3TerminatedNegovsky Reanimatology Research Institute1072021-11-202025-09-25
Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)
Lithium Carbonate 400 MG - Amyotrophic Lateral Sclerosis
Phase 3TerminatedStichting TRICALS Foundation882021-08-092026-05-13
Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients
Lithium Carbonate - Neutropenia
Phase 3CompletedAl-Azhar University502020-08-012022-10-21
Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3
Lithium Carbonate, Placebo - Spinocerebellar Ataxia Type 3, Machado Joseph Disease
Phase 2 / Phase 3CompletedHospital de Clinicas de Porto Alegre622011-05-012013-01-30
Safety and Efficacy Study of Lithium for the Treatment of Pediatric Mania.
Lithium Carbonate, Placebo - Bipolar Disorder
Phase 2 / Phase 3CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)812010-06-012013-10-09
The Neurotrophic Effects of Lithium Carbonate Following Stroke: A Feasibility Study
Lithium Carbonate - Stroke
Phase 3CompletedSunnybrook Health Sciences Centre122010-04-012024-01-31
Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression
Quetiapine fumarate XR, Lithium carbonate - Acute Bipolar Depression
Phase 3CompletedAstraZeneca4212009-04-012012-07-11
Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
Lithium Carbonate, Riluzole, placebo - Amyotrophic Lateral Sclerosis
Phase 2 / Phase 3TerminatedMassachusetts General Hospital842009-01-012011-04-19
Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients
Quetiapine XR, Lithium carbonate, SSRI/Venlafaxine - Major Depressive Disorder, Treatment Resistant Depression
Phase 3CompletedAstraZeneca6882008-11-012012-05-23
Lithium Versus Paroxetine in Patients With Major Depression Who Have a Family History of Bipolar Disorder or Suicide
paroxetine, lithium - Major Depressive Disorder
Phase 3TerminatedNova Scotia Health Authority22007-06-012021-01-29
Safety and Efficacy Study of Lithium in Bipolar Disorder
Lithium Carbonate Capsule - Bipolar Disorder, Mania
Phase 3UnknownJDS Pharmaceuticals2062007-01-012007-08-14
Bipolar II Depression: Lithium, SSRI, or the Combination
Sertraline, Lithium carbonate - Bipolar Disorder, Depression
Phase 3CompletedLindner Center of HOPE1392006-09-012013-05-10
Treatment of Mania Symptoms With Drug Therapy
Divalproex-extended release (DVP-ER), Lithium, Quetiapine - Bipolar Disorder, Schizophrenia
Phase 3CompletedPalo Alto Veterans Institute for Research752005-02-012018-07-17
Olanzapine Versus Comparator in the Treatment of Bipolar Disorder
Olanzapine Hydrochloride, Lithium Carbonate - Bipolar Disorder
Phase 3CompletedEli Lilly and Company1402003-12-012007-06-13
Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents
Lithium carbonate, Valproate, Risperidone - Bipolar Disorder
Phase 3CompletedWashington University School of Medicine3792003-02-012013-04-04
Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode
Valproate, Lithium, Risperidone - Bipolar I Disorder
Phase 3CompletedUniversity of British Columbia1592003-01-012015-11-20
Combination Therapy in Dual Diagnosis Bipolar Rapid Cycling
Divalproex, Lamotrigine, Lithium - Bipolar Disorder
Phase 3CompletedUniversity Hospitals Cleveland Medical Center982002-07-012014-12-03
Combination Therapy for the Treatment of Bipolar Disorders
Lithium, Lamotrigine, Divalproex - Bipolar Disorder
Phase 3TerminatedUniversity Hospitals Cleveland Medical Center492002-02-012016-11-07

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Bipolar Disorder (12)  ·  Depression (4)  ·  Mania (3)  ·  Amyotrophic Lateral Sclerosis (2)  ·  Depressive Disorder, Major (2)  ·  Stroke (2)  ·  Autism Spectrum Disorder (1)  ·  Autistic Disorder (1)  ·  Carotid Artery Diseases (1)  ·  Carotid Stenosis (1)  ·  De Lange Syndrome (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Emergence Delirium (1)  ·  Machado-Joseph Disease (1)  ·  Nerve Degeneration (1)

Sponsors

University Hospitals Cleveland Medical Center (3)  ·  AstraZeneca (2)  ·  Al-Azhar University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Eli Lilly and Company (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Hospital de Clinicas de Porto Alegre (1)  ·  JDS Pharmaceuticals (1)  ·  Lindner Center of HOPE (1)  ·  Massachusetts General Hospital (1)  ·  Negovsky Reanimatology Research Institute (1)  ·  Nova Scotia Health Authority (1)  ·  Palo Alto Veterans Institute for Research (1)  ·  Stichting TRICALS Foundation (1)

Countries

United States (9)  ·  Canada (4)  ·  Australia (2)  ·  Belgium (2)  ·  Brazil (2)  ·  Italy (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Austria (1)  ·  Bulgaria (1)  ·  Chile (1)  ·  China (1)  ·  Colombia (1)  ·  Denmark (1)

Top investigators

Keming Gao, MD, PhD (2)  ·  Aglaia Vignoli, Professor, MD (1)  ·  Andree Daigneault, Dr. (1)  ·  Ayal Schaffer, Dr. (1)  ·  Barbara Geller, MD (1)  ·  Benny Lafer, Dr. (1)  ·  Birgit Ekholm, PhD (1)  ·  Claire O'Donovan M O'Donovan, MB FRCPC (1)  ·  Claire O'Donovan, Dr. (1)  ·  Delorme Richard, PHD (1)  ·  Ellen Frank, PhD (1)  ·  Flavio Kapczinski, Dr. (1)  ·  Hubert Wong, Dr. (1)

Results publications

PMID 18588360, PMID 10609422, PMID 10831476, PMID 10941997, PMID 11018230, PMID 11196004, PMID 11256459, PMID 11522262, PMID 11593071, PMID 11748774, PMID 11772699, PMID 11874212, PMID 12027038, PMID 16143731, PMID 17335331, PMID 19192457, PMID 20363190, PMID 22213771, PMID 22917200, PMID 23810357, PMID 24399647, PMID 26297649, PMID 26459650, PMID 26598475, PMID 26598476, PMID 26975266, PMID 30566418, PMID 30738555, PMID 35235061, PMID 37794802, PMID 8993082, PMID 9171907, PMID 9262937, PMID 9707380

NIH funding

R01MH050165 (1), R01MH063632 (1), R01MH069801 (1), R01MH074707 (1), R21MH062650 (1), U01MH064846 (1), U01MH064850 (1), U01MH064868 (1), U01MH064869 (1), U01MH064887 (1), U01MH064911 (1), U01NS049640 (1)